05:16:41 EDT Tue 22 Oct 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
AI-ML Innovations Inc
Symbol AIML
Shares Issued 117,120,864
Close 2024-10-21 C$ 0.165
Market Cap C$ 19,324,943
Recent Sedar Documents

AI-ML arranges $1.3-million private placement

2024-10-21 20:35 ET - News Release

Mr. Tim Daniels reports

AI/ML INNOVATIONS INC. ANNOUNCES PROPOSED PRIVATE PLACEMENT

AI-ML Innovations Inc. intends to complete a non-brokered private placement offering of up to 20 million units at a price of 6.5 cents per unit for gross proceeds of up to $1.3-million. Each unit is composed of one common share and one warrant, which will be exercisable into one common share of the company. Each warrant will have a term of two years and will entitle the holder to purchase one warrant share at a price of 15 cents per share following the closing date, subject to the company's right to accelerate expiry upon 30 days notice if the shares trade at 30 cents for a 10-day period.

The common shares and warrants comprising the units will be subject to a four-month-and-one-day hold period in accordance with the policies of the Canadian Securities Exchange and applicable securities legislation.

The company intends to use net proceeds of the private placement for working capital requirements.

The company will pay a finder's fee to qualified finders who assist in selling the units, in cash, securities or a combination of both, as permitted by CSE policy and applicable securities laws.

The private placement is subject to certain conditions, including, but not limited to, the receipt of all necessary approvals, including approval from the Canadian Securities Exchange.

About AI-ML Innovations Inc.

AI-ML has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence and machine learning, with an initial investment focus on emerging digital health and well-being companies that leverage AI, ML, cloud computing and digital platforms to drive transformative health care management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70 per cent owned by AI-ML), Tech2Heal (22-per-cent ownership commitment by AI-ML), AI Rx Inc. (70 per cent owned by AI-ML) and other planned accretive investments, the company continues to capitalize on expanding growth areas, to the benefit of all the company's stakeholders. AI-ML's shares are traded on the Canadian Securities Exchange under the symbol AIML, on the OTCQB Venture Market under AIMLF and on the Frankfurt Stock Exchange under 42FB.

© 2024 Canjex Publishing Ltd. All rights reserved.